OCRFA Founder Sol Schreiber passes away
OCRFA Founder Sol Schreiber passes away
With deep sorrow, Ovarian Cancer Research Alliance mourns the passing of our beloved founder and Chairman Emeritus, Sol Schreiber.
News
OCRFA Research Shows Genetic Subtypes Linked to Increased R...
OCRFA Research Shows Genetic Subtypes Linked to Increased Risk of Ovarian Cancer
(June 9, 2016) A ten year, OCRFA-funded study has revealed the effect that the human leukocyte antigen (HLA) genes, which help regulate the body’s immune system, have on how the body responds to treatment of epithelial ovarian cancer. The scientists report that women with certain types of HLA may have an increased risk of ovarian … Continued
Risk Factors and Outcomes for Chemotherapy Refusal
Risk Factors and Outcomes for Chemotherapy Refusal
(June 7, 2016) The Journal of the National Comprehensive Cancer Network recently published a study that looked at the difference in outcomes between two groups of epithelial ovarian cancer patients: those who received recommended, multiagent chemotherapy and those who chose not to undergo the recommended treatment. After tracking thousands of patients in both groups, the … Continued
SherryStrong.org
In August of 2014, Sherry Pollex became a part of this incredible, strong, inspirational and ever beautiful community of ovarian cancer survivors. OCRA first got to know Sherry when she was first diagnosed. We knew right away that Sherry was a special person, when her first question was, “How can I help save other women … Continued
The Impact of BMI on IP Therapy
The Impact of BMI on IP Therapy
(May 25, 2016) A new study published in the International Journal of Gynecological Cancer earlier this month investigated the impact of body mass index (BMI) on completion, complications, and clinical outcomes of intraperitoneal (IP) chemotherapy in patients with advanced-stage ovarian cancer. The study followed ninety two patients through a minimum of one cycle of IP … Continued
Action Alert: Protect Ovarian Cancer Research Funding at th...
Action Alert: Protect Ovarian Cancer Research Funding at the Department of Defense
Later this week, we’ll be sending out a request for you to take Action to help protect ovarian cancer research funding at the Department of Defense. The Ovarian Cancer Research Program (OCRP) is part of the Congressionally Directed Medical Research Program in the Department of Defense (DoD), and funds innovative and cutting edge ovarian cancer … Continued
Newk's Unites 100 Restaurants to Raise $100,000 for Ov...
Newk's Unites 100 Restaurants to Raise $100,000 for Ovarian Cancer Research
Foodie Fast-Casual Brand Reaches Halfway Point in Its 200-Unit Growth Plan JACKSON, Miss. — Pairing a big moment with a big cause, fast-casual Newk’s Eatery is celebrating its centennial restaurant opening by uniting system-wide to raise $100,000 for ovarian cancer research starting April 4. Each of Newk’s 100 restaurants has committed to raising $1,000, inviting … Continued
Newk's Raises more than $110,000 for OCRFA
Newk's Raises more than $110,000 for OCRFA
When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis. Blindsided and heartbroken by a type of cancer very few recognize or understand, Lori and her husband Chris, Co-founder and CEO of Newk’s Eatery, saw an opportunity to save women’s … Continued
Zubik v. Burwell & the Supreme Court
Zubik v. Burwell & the Supreme Court
FOR IMMEDIATE RELEASE May 17, 2016 Lisa Mauti lmauti@ocrfa.org 202-517-6410 Supreme Court Returns Zubik v. Burwell to Lower Courts to Resolve Access to Cost-Free Contraceptive Services to Women “We urge the lower courts to move quickly and to consider the impact of their decision on the future of women’s preventative healthcare, especially as a … Continued
Webinar: Clinical Trials: What you need to know
Webinar: Clinical Trials: What you need to know
Oliver Dorigo, MD, PhD, Director of the Stanford Gynecologic Oncology Clinical Care Program and Director of Stanford Obstetrics and Gynecology’s Division of Gynecologic Oncology provided an introduction to clinical trials for ovarian cancer patients. Dr. Dorigo discussed what clinical trials are, why they are important and how they work, the pros and cons of enrolling … Continued
Long Term Survival Study Recruiting Participants
Long Term Survival Study Recruiting Participants
The Consortium for Long-Term Survival — is bringing together research groups worldwide. These groups include survivors, patient advocates and advocacy groups, (not just researchers) with the goal of “FINDING THE KEY TO LONG-TERM SURVIVAL FOR ALL WOMEN.” RECRUITING NOW: 8+ year survivors, STAGE 3 or 4 ONLY, contact Giulia Fulci, gfulci@partners.org or 617-643-7261. View more … Continued
OCRFA Research Helps Explain Resistance to Chemotherapy
OCRFA Research Helps Explain Resistance to Chemotherapy
(May 4, 2016) Research funded in part by an OCRFA research grant to Dr. Weiping Zou at the University of Michigan has shown that the sensitivity and resistance to cancer chemotherapies is not fully explained by genomic mechanisms as it has previously thought. In fact, it may be affected by effector T cells (cells that defend … Continued